Barely Significant
← all excerpts

The impact of eligibility criteria on Kirsten rat sarcoma G12C inhibitor trials in patients with non-small cell lung cancer.

J Natl Cancer Inst · 2026 · PMC12794216 · PMID 40845174

Europe PMCDOI
1
hedged sentence
0.0040
closest p · 0.1× alpha
0.0040
boldest claim

The sentences

highly significantP = .004actually significant
As expected, trial-eligible patients had better overall survival than ineligible patients, but this was not statistically significant in the first-line (HR = 0.747, P = .148), whereas the effect was highly significant in the second-line (HR = 0.423, P = .004).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.